LAGUNA HILLS, Calif., April 11, 2019 /CNW/ -- Sonendo, the manufacturer of the GentleWave System®, today reported that they had shipped more than 200,000 GentleWave Procedure Instruments.
About achieving this milestone, Sonendo President and CEO, Bjarne Bergheim said, "We are excited to see demand for the GentleWave Procedure continuing to grow – both for consoles and procedure instruments. We believe this increase in demand reflects our commitment to partner with endodontists and drive improvements in clinical efficacy and practice efficiency."
Sonendo.com offers perspectives from endodontists across North America on how the GentleWave System is helping providers redefine their practice, streamline processes, and improve patient care. The GentleWave System officially launches this week in Canada at the American Association of Endodontists (AAE) annual meeting in Montreal, Canada.
Sonendo, Inc. is a privately-held company developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO™ Software, the developer of the most widely used endodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
1Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2Molina B et al. (2015) J Endod. 41:1701-05. 3Trope M et al. (1999) J Endod. 25:345–50.
This announcement contains forward-looking statements based on management's beliefs, assumptions and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
Vice President of Marketing